Authors


Caitlyn Bradford, PharmD

Latest:

Review of FDA Approvals for Pediatric Obesity Management

GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.


Reina Puri

Latest:

Best Practices on Discussing Birth Control for Adolescents

There are numerous methods of contraception available for adolescents.



Leah Habersham, MD, MBA, MS

Latest:

Assessing and Treating Opioid Use Disorder in Pregnancy

Opioid use disorder during pregnancy is stigmatized, but these patients deserve compassionate, nonjudgmental care.




Sobha Pisharody

Latest:

The Increasingly Relevant Role of Pharmacogenomics

Pharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.




Beth Brooks, PhD, RN, FACHE

Latest:

Health Care Hiring Trends For 2023 And Beyond

How are hiring trends shaping up for the future of health care?


Kevin Chamberlain, PharmD, FASCP

Latest:

Quizartinib Approved for Newly Diagnosed AML in Patients with ITD

Overall median survival was higher in participants taking quizartinib, according to results from QuANTUM-First trial.


Andre Wang, PharmD

Latest:

New Prodrug for ADHD in School-aged Children

Ser/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.


Satish Srinivasan, MS

Latest:

Could a Cash-Based System Help Eliminate Health Care Barriers?

Disadvantaged groups are feeling the sting of health care costs—so much so that many are foregoing health care because they can’t pay for it.


Tim Gregorius, RPh

Latest:

Use This Checklist To Select Your CBD Product

What pharmacists need to consider before selling CBD in their stores.


Alana Galipeau, PharmD Candidate

Latest:

OTC Considerations for COVID-19

Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves


Ruby Barghini, MD

Latest:

Apetamin Gains Popularity on Social Media as Weight Gain Drug

Apetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?


Lisa Faast, PharmD, DiversifyRx CEO

Latest:

How to Increase CBD Sales at Your Independent Pharmacy

Tips to help your pharmacy stand out as a knowledgeable CBD retailer.


Kendall Haney, PharmD Candidate

Latest:

COVID-19 Therapy Pipeline Update

Here’s an overview of what’s in the late-stage pipeline.



Richard Payerchin

Latest:

Opioid Use Disorder Treatment Inconsistent Around United States

At the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.


Lynda Charters

Latest:

AMD Risk Not Tied to Long-Term Metformin Use

The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.


Brandon May

Latest:

Mitigating Costs of Cancer Treatment: The Role of Pharmacists

Cancer care is expensive, but pharmacists can help.


Heather Raglin

Latest:

Anti-PD-1 Therapy for Melanoma Associated With Chronic Immune-Related Adverse Events

The majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.


Sara Elsaid Taha, BPS, PharmD Candidate 2022

Latest:

Vitamin D and COVID-19: An Evidence-Based Review

In this article, we will review the evidence describing a possible link between vitamin D and COVID-19.


Nardine Karam, BPS, PharmD candidate

Latest:

A Review of FDA-Approved Medications for Chronic Weight Management

Five medications are currently approved by the FDA for chronic weight management.



Kathleen Beitzel

Latest:

The Ever-Expanding Role of Consultant Pharmacists in Long-term Care

Clinical consultant pharmacists offer an individualized approach to the needs of long-term care facilities.


Kendall Szulimowski, 2021 PharmD candidate

Latest:

Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma

Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.


Scotty Sykes, CPA, CFP

Latest:

Coming out of COVID: 5 Objectives for Boosting Rx Business and Cash Clinical Services

Ollin Sykes, CPA, CITP, and Scotty Sykes, CPA, CFP, discuss the business landscape after COVID within pharmacies and 5 objectives for focusing on growth again.


© 2024 MJH Life Sciences

All rights reserved.